Validation and application of a prognostic model for patients with advanced pancreatic cancer receiving palliative chemotherapy

BACKGROUND: We previously developed a robust prognostic model (GS model) to predict the survival outcome of patients with advanced pancreatic cancer (APC) receiving palliative chemotherapy with gemcitabine plus S‐1 (GS). This study aimed to validate the application of the GS model in APC patients re...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Med
Main Authors: Huang, Pei‐Wei, Chang, Ching‐Fu, Hung, Chia‐Yen, Hsueh, Shun‐Wen, Chang, Pei‐Hung, Yeh, Kun‐Yun, Chen, Jen‐Shi, Chen, Yen‐Yang, Lu, Chang‐Hsien, Hung, Yu‐Shin, Chou, Wen‐Chi
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Clinical Cancer Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6745849/
https://ncbi.nlm.nih.gov/pubmed/31385456
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2483
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados